bluebird bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of bluebird bio generated cash of -$235,046,000, which is more than the previous year. Cash used in financing activities reached the amount of $196,248,000 last year. Net change in cash is therefore $116,152,000.
Cash Flow
| 2014 | -59.69M | -157.19M | 358.45M |
|---|---|---|---|
| 2015 | -98.42M | -571.86M | 486.72M |
| 2016 | -189.64M | 62.73M | 241.53M |
| 2017 | -280.55M | -316.00M | 1.07B |
| 2018 | -413.42M | -679.43M | 737.69M |
| 2019 | -564.38M | 507.80M | 21.18M |
| 2020 | -470.35M | -84.34M | 546.71M |
| 2021 | -635.63M | 562.55M | -93.95M |
| 2022 | -352.95M | 250.45M | 54.25M |
| 2023 | -235.04M | 154.95M | 196.24M |
BLUE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 158.44M | 206.69M | 373.72M | 381.70M | 417.09M | 772.26M | 278.88M | 164.26M | 347.84M | 206.27M |
Operating activities | ||||||||||
Net income | -211.91M | -266.57M | -819.37M | -618.69M | -789.60M | -555.62M | -335.64M | -263.50M | -166.78M | -48.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 28.52M | 5.00M | 19.64M | 19.35M | 17.43M | 17.15M | 13.53M | 9.64M | 7.41M | 4.22M |
Stock-based compensation expense | 19.42M | 35.18M | 127.91M | 156.63M | 160.62M | 0 | 53.28M | 39.75M | 41.12M | 10.76M |
| Deferred income tax benefit | 19.42M | 35.18M | 127.91M | 156.63M | 160.62M | 0 | 53.28M | 39.75M | 41.12M | 10.76M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 32.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 15.36M | -7.22M | -18.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.84M | -920K | 9.28M | -20.1M | 23.6M | 3.61M | 526K | 6.65M | 2.54M | -2.24M |
Cash generated by operating activities | -235.04M | -352.95M | -635.63M | -470.35M | -564.38M | -413.42M | -280.55M | -189.64M | -98.42M | -59.69M |
Investing activities | ||||||||||
Purchases Of Investments | -43.29M | 0 | -451.39M | -1.00B | -756.57M | -1.51B | -686.20M | -348.22M | -755.17M | -174.98M |
Investments In Property Plant And Equipment | -4.18M | -13.20M | -23.00M | -28.98M | -76.25M | -55.73M | -62.24M | -15.99M | -7.05M | -8.70M |
Acquisitions Net | 0 | 0 | 8.5M | 55.35M | 5.22M | 0 | 0 | 0 | 0 | -4.67M |
Cash generated by investing activities | 154.95M | 250.45M | 562.55M | -84.34M | 507.80M | -679.43M | -316.00M | 62.73M | -571.86M | -157.19M |
Financing activities | ||||||||||
Common Stock Issued | 248.19M | 54.23M | 80.33M | 541.53M | 21.18M | 703.85M | 1.00B | 241.89M | 487.17M | 353.22M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -54.36M | -36.73M | 0 | -17.38M | 0 | -1.01M | 37.44M | 0 | 0 | 0 |
Cash used in financing activities | 196.24M | 54.25M | -93.95M | 546.71M | 21.18M | 737.69M | 1.07B | 241.53M | 486.72M | 358.45M |
Net Change In Cash | 116.15M | -48.24M | -167.03M | -7.98M | -35.39M | -355.16M | 479.61M | 114.61M | -183.57M | 141.56M |
Cash at end of period | 274.59M | 158.44M | 206.69M | 373.72M | 381.70M | 417.09M | 758.50M | 278.88M | 164.26M | 347.84M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |